Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Substances in compounding that may present significant safety risks
Alternative Names: Body Protection Compound-157, Pentadecapeptide BPC-157 BPC-157 Studies and Research Data BPC-157 Research on Wound Closure and Tissue Integrity Preclinical studies propose that BPC-157 may support wound repair by influencing fibroblast activity
Follow the schedule they set
COMPOUNDED MEDICATION DISCLOSURE: Compounded medications, including compounded semaglutide and tirzepatide, are not FDA-approved drugs and have not been evaluated by the U.S
They are complementary compounds that address different phases of the same repair process
Fixed ratio: GHK-Cu 50 mg : BPC-157 10 mg : TB-500 10 mg : KPV 10 mg a 5:1:1:1 blend
US$ 26.48
US$ 20.76
US$ 27.16
US$ 25.81
